Search Results (933)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19. | Academic Article |
Why?
|
| [Fatal embolism after gynecological surgery; contribution to evaluation of thromboembolism prevention and early anticoagulant therapy]. | Academic Article |
Why?
|
| Anticoagulant options in atrial fibrillation: When new treatments become standard practice. | Academic Article |
Why?
|
| Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing. | Academic Article |
Why?
|
| Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions. | Academic Article |
Why?
|
| The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes. | Academic Article |
Why?
|
| Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. | Academic Article |
Why?
|
| Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study. | Academic Article |
Why?
|
| Drug Interactions With Non-Vitamin K Oral Anticoagulants. | Academic Article |
Why?
|
| Emerging anticoagulants for venous thromboembolism prevention. | Academic Article |
Why?
|
| New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants. | Academic Article |
Why?
|
| Novel oral anticoagulants and reversal agents: Considerations for clinical development. | Academic Article |
Why?
|
| Select Drug-Drug Interactions With Direct?Oral Anticoagulants: JACC Review Topic of the Week. | Academic Article |
Why?
|
| The New Direct-Acting Oral Anticoagulants Need to be Monitored! | Academic Article |
Why?
|
| Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. | Academic Article |
Why?
|